| Released | Contributor | Author | Title | Pages | Price |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| AP Pharma | 4 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | AP PHARMA INC (APPA=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | AP PHARMA INC (APPA=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: AP PHARMA -- APPA | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AIS , APPA , CPRX , NLTX , NBY , PCYC , VRUS , DDD -- DRUGS | 3 |
$4 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for APPA | 13 |
$25 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: AP PHARMA INC | 5 |
$25 |
| 17-Nov-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for APPA: the economy's impact on APPA's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 14-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: AP PHARMA INC | 5 |
$25 |
1.48% Nasdaq 
0.01 (1.08%) 
Research Reports
